二氯甲基醚置于brf3体系中,化学反应生成七氟烷 参考文献:Method For The Preparation Of Fluoromethyl 标题:Method For The Preparation Of Fluoromethyl 摘要:氟甲基-1,1,1,3,3,3-六氟-2-丙基醚的制备是通过溴三氟和甲基-1,1,1,3,3,3-六氯-2-丙基醚或氯甲基-1,1,1,3,3,3-六氯-2-丙基醚反应得到的.具有公式##str1##(其中x+y=3,A+b=3,Z=h Cl或f)的混合氟氯醚中间体通过与溴三氟反应转化为氟甲基-1,1,1,3,3,3-六氟-2-丙基醚.
专利号:US-2012177593-A1 优先权日:2009-07-20 标 题 :Synthesis of dendrimer conjugates 发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH 权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN 摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.
专利号:US-7375254-B2 优先权日:2003-01-14 标题:Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis 发明人:ROZOV LEONID A; LESSOR RALPH A 权利人:BAXTER INT 摘要:Provided is a process of obtaining 1,1,1,3,3,3-hexafluoro-2-propanol (“HFIPâ€?) from a composition comprising an HFIP hydrolyzable precursor. The HFIP hydrolyzable precursor is a compound, other than sevoflurane itself, that has an intact 1,1,1,3,3,3-hexafluoroisopropoxy moiety[(CF 3 ) 2 CHO—], and contains one or more moieties susceptible to acidic hydrolysis, such that HFIP is released upon such treatment. The process is useful, among other things, for recovering HFIP from waste streams associated with the synthesis of the inhalation anesthetic, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether (“sevofluraneâ€?). The process includes heating the composition with a strong protic acid to a temperature effective to hydrolyze at least some of the HFIP hydrolyzable precursor to HFIP, and then isolating the HFIP from the heated composition.
专利号:US-5705710-A 优先权日:1997-01-15 标 题 :Process for the synthesis of hexafluoroisopropyl ethers 发明人:BAKER MAX T; TINKER JOHN H; RUZICKA JAN A 权利人:UNIV IOWA RES FOUND 摘要:This invention relates to a method of synthesizing 1,1,1,3,3,3-hexafluoroisopropyl ether compounds from the reaction of methoxymalanonitrile with a bromine trifluoride composition.
专利号:US-5789630-A 优先权日:1996-02-27 标题:Process for the synthesis of hexafluoropropanes 发明人:BAKER MAX T; RUZICKA JAN A 权利人:UNIV IOWA RES FOUND 摘要:The invention relates to a method of synthesizing 1,1,1,3,3,3-hexafluoropropanes comprsing the additon of BrF 3 to malononitrile.
专利号:US-2015352230-A1 优先权日:2013-01-11 标 题:Synthesis and isolation of dendrimer based imaging systems 发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK 权利人:UNIV MICHIGAN 摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).
专利号:US-7605291-B2 优先权日:2006-04-27 标 题 :Method for the preparation of volatile Anesthetics 发明人:MALDONADO ADALBERTO 权利人:MALDONADO ADALBERTO 摘要:The present invention is concerned with the automated control of the synthesis and purification of components useful in the synthesis and purification of volatile anesthetics. The invention is particularly useful in its application to the purification of acetone used in the purification of isoflurane.
参考文献:10.1007/s00540-010-0889-2 摘要:Shiotsuka J, Sanui M, Lefor A. Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency. Journal of Anesthesia. 2010 Feb 13;24(2):309–10. doi: 10.1007/s00540-010-0889-2. 参考文献:10.1186/cc8875 摘要:Mayer J, Boldt J, Mengistu AM, Röhm KD, Suttner S. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care. 2010;14(1):R18. 参考文献:10.1016/j.joms.2008.12.012 摘要:Rossi A, Falzetti G, Donati A, Orsetti G, Pelaia P. Desflurane Versus Sevoflurane to Reduce Blood Loss in Maxillofacial Surgery. Journal of Oral and Maxillofacial Surgery. 2010 May;68(5):1007–12. doi: 10.1016/j.joms.2008.12.012. 参考文献:10.1007/s00259-010-1392-6 摘要:Eder M, Knackmuss S, Le Gall F, Reusch U, Rybin V, Little M, Haberkorn U, Mier W, Eisenhut M. 68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours. European Journal of Nuclear Medicine and Molecular Imaging. 2010 Feb 16;37(7):1397–407. doi: 10.1007/s00259-010-1392-6. 参考文献:10.1007/s00259-010-1384-6 摘要:Schoultz BW, Hjornevik T, Willoch F, Marton J, Noda A, Murakami Y, Miyoshi S, Nishimura S, Årstad E, Drzezga A, Matsunari I, Henriksen G. Evaluation of the kappa-opioid receptor-selective tracer [11C]GR103545 in awake rhesus macaques. European Journal of Nuclear Medicine and Molecular Imaging. 2010 Feb 16;37(6):1174–80. doi: 10.1007/s00259-010-1384-6.